Keegan Bradley hosts Children’s Cancer and Opiate Addiction Research Fundraiser
Woodstock Inn & Resort, Aug. 25
Vermont native Keegan Bradley, the 2011 PGA Tour Rookie of the year and a star of the 2012 U.S. Ryder Cup team, returns to the Woodstock Inn & Resort Aug. 25 with fellow PGA Tour winner Brendan Steele to host the third annual Keegan Bradley Charity Golf Classic.
The event benefits the Pediatric Cancer Research Foundation in its support of the Vermont Cancer Center and Vermont Children’s Hospital at the University of Vermont and Fletcher Allen Health Care to fund life-saving research for children battling cancer. Also, in recognition of Governor Peter Shumlin’s commitment to fight opiate addiction in Vermont, a portion of the proceeds will also benefit opiate addiction research and treatment programs at the University of Vermont and Fletcher Allen Health Care.
“Our tournament has been a great success the last two years on behalf of the Vermont Cancer Center,” said Bradley. “Childhood cancer and drug addiction deeply affect all of us Vermonters, and this year I’m proud to do what I can to raise awareness and funds for both those causes with the public’s help.”
The day begins at 11 a.m. with a free golf clinic with Keegan and Brendan. A reception follows play for 24 foursomes. Fans who would like to attend the clinic, purchase a $100 reception ticket or contribute to the cause may do so by visiting the event website: www.keeganbradley.com/charity.php.
Putnam Investments is again the presenting sponsor of the event. Leading additional underwriters include National Car Rental, Sugarbush, Zurich, Audemars Piguet and Srixon/Cleveland Golf.
"Putnam is pleased to partner with Keegan -- for a third year in a row -- to help fund life-saving research and provide much needed services for children battling cancer and their families in Vermont," said Robert L. Reynolds, President and CEO, Putnam Investments.
“I appreciate Keegan’s personal commitment to the fight against both pediatric cancer and opiate addiction, two critical issues that threaten the safety and health of our children and communities,” Gov. Shumlin said. “Keegan’s success on the PGA tour has already made Vermonters proud. His work over the past three years raising funds and awareness on these critical issues in his native Vermont makes us even more proud of Keegan. I thank Keegan for helping us improve life here at home.”
Jeri Wilson, executive director of PCRF, said, “With funding for pediatric cancer research declining, we are grateful to Keegan for his incredible generosity and recognize his support of our families fighting cancer. I know the Vermont Cancer Center will strive every day to ensure their research delivers the greatest impact both locally and nationally.”
Media availability runs from 11am – 12pm with the golf clinic hosted by Keegan and Brendan, followed by a fan autograph session and group interview and photo opportunities.
About Pediatric Cancer Research Foundation (PCRF)
The Pediatric Cancer Research Foundation (PCRF) is an independent, nonprofit organization, wholly dedicated to funding leading-edge pediatric cancer research nationwide. Since its founding in 1982, PCRF has raised over $32 million dollars towards the ultimate goal of ending pediatric cancers so children and their families can re-focus on the joys of childhood. This commitment has translated into immediate treatment for children with cancer by developing innovative treatment protocols; improving patients’ long-term quality of life; and supporting those scientists working on the precipice of important medical breakthroughs. For more information, please visit www.PCRF-kids.org, or contact Executive Director Jeri Wilson at [email protected].
About the Vermont Cancer Center
The Vermont Cancer Center at the University of Vermont and Fletcher Allen Health Care in Burlington, Vermont is a comprehensive clinical and research cancer center committed to innovative cancer research, life-saving prevention and treatment programs, public education, and scientific collaboration. With more than 130 scientists engaged in a full range of basic, translational, clinical and outcomes research, the VCC plays an important role in cancer prevention and treatment across the Vermont and Northern New York region and beyond. Through the collaborations of researchers, physicians, and caregivers, the Vermont Cancer Center brings advanced treatment options to patients in our region, including hundreds of clinical trials aimed at advancing the standard of care and improving overall quality of life for cancer patients. To learn more about research, education, prevention, patient care, and support at the VCC, visit www.vermontcancer.org.
United States